(Q33653359)

28 July 2017

1 reference

title

Laboratory identification of hereditary risk of breast and ovarian cancer (English)

1 reference

28 July 2017

1 reference

Frank TS

1

1 reference

28 July 2017

language of work or name

1 reference

1 June 1999

1 reference

Current Opinion in Biotechnology

28 July 2017

published in

1 reference

28 July 2017

volume

10

1 reference

28 July 2017

issue

3

1 reference

28 July 2017

page(s)

289-294

1 reference

Isolation of a transforming sequence from a human bladder carcinoma cell line

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

From bench top to bedside

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Genetic testing for cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Linkage of early-onset familial breast cancer to chromosome 17q21

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Association of BRCA1 with Rad51 in mitotic and meiotic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

BRCA1 required for transcription-coupled repair of oxidative DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Double-strand break repair deficiency and radiation sensitivity in BRCA2 mutant cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

BRCA-associated breast cancer in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

High Frequency of BRCA1 and BRCA2 Germline Mutations in Ashkenazi Jewish Ovarian Cancer Patients, Regardless of Family History

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

New BRCA2 mutation in an Ashkenazi Jewish family with breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Population-based study of risk of breast cancer in carriers of BRCA2 mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

SSCP analysis: A blind sensitivity trial

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Molecular diagnostics: issues of utilization, regulation and organization

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS0958-1669%2899%2980051-2

7 January 2021

10.1016/S0958-1669(99)80051-2

Identifiers

DOI

1 reference

28 July 2017

1 reference